Header Logo

Connection

SETH LERNER to Leukemia, B-Cell

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about Leukemia, B-Cell.
SETH LERNER
Connection Strength
0.047
Leukemia, B-Cell
  1. Rituximab dose-escalation trial in chronic lymphocytic leukemia. J Clin Oncol. 2001 Apr 15; 19(8):2165-70.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.